Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label randomized Phase IV trial of Fosavance versus referred care in postmenopausal women with osteoporosis at increased risk of falls
2008-001153-17Phase 4Completed
- Sponsor
- Merck & Co.
- Start
- Apr 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of alendronate + cholecalciferol in osteoporosis (2 arms), sponsored by Merck & Co. Primary endpoint: Proportion of patients with serum 25(OH)D <20 ng/mL at week 26. Started Apr 2008; status: completed.
02
Drugs
alendronate + cholecalciferol
03
Conditions
osteoporosis
Beyond the preview
Go deeper on 2008-001153-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-001153-17.